查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018075

體外膜氧合（ECMO）設備市場：按設備類型、組件類型、患者類型、應用和最終用戶分類－2026-2032年全球市場預測

Extracorporeal Membrane Oxygenation Machine Market by Device Type, Component Type, Patient Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，體外膜氧合 (ECMO) 市值將達到 5.7925 億美元，到 2026 年將成長至 6.1075 億美元，到 2032 年將達到 8.4014 億美元，複合年成長率為 5.45%。

主要市場統計數據
基準年 2025 5.7925億美元
預計年份：2026年 6.1075億美元
預測年份 2032 8.4014億美元
複合年成長率 (%) 5.45%

對體外膜氧合（ECMO）進行權威概述，這是一種成熟的先進支持療法，它重塑了重症監護的路徑和採購重點。

體外膜氧合（ECMO）已逐漸被臨床實踐所接受，並在設備技術的穩步發展推動下，從一種小眾的救命療法發展成為高級重症監護中不可或缺的選擇。目前，臨床醫生將ECMO視為一種“橋樑療法”，用於穩定因急性呼吸衰竭或心臟衰竭而處於危急狀態的患者病情，同時尋求根治性治療或器官功能恢復。因此，醫療系統和臨床團隊正在修訂相關流程，組成多學科ECMO團隊，並增加培訓和模擬訓練的投入，以確保ECMO安全啟動和撤機。

技術創新、業務流程重組和在地化醫療保健網路如何改變體外療法的交付方式以及與供應商的關係。

體外膜氧合（ECMO）的現況正受到多項因素的共同影響，這些因素不僅影響設備升級，也影響臨床工作流程、供應鏈和服務模式。泵浦技術、氧合器效率和表面塗層的進步降低了溶血和血栓併發症，從而實現了更長時間、更安全的運作。同時，雙腔插管策略和經皮途徑的興起縮短了部署時間，提高了設備的便攜性，使得在緊急情況和轉運環境中能夠快速啟動治療。

2025 年的關稅變化需要對外部系統的籌資策略和零件本地化進行審查，以提高供應鏈的韌性和採購的靈活性。

2025年美國關稅調整為體外膜氧合（ECMO）系統的設備、組件採購和供應鏈韌性帶來了新的趨勢。對某些醫療組件和子組件徵收的進口關稅提升了籌資策略的重要性，促使醫療設備製造商和醫院重新評估供應商所在地、本地組件在地採購和庫存政策。為此，一些製造商加快了對替代供應商的認證，並確保了物流管道的多元化，以減少對單一國家採購的依賴。

基於細分市場的洞察：揭示醫療設備類型、組件專業化、患者人口統計特徵、臨床應用和最終用戶環境如何影響策略重點。

細分市場分析揭示了醫療設備類型、組件、患者族群、臨床應用和終端用戶環境等方面的不同趨勢，為產品策略和市場進入方式提供了全面的指南。根據醫療設備類型，此領域可分為兩類：一類是針對心臟支持的靜脈-動脈（VA）系統，另一類是專門用於呼吸支持和體外膜氧合（ECMO）的靜脈靜脈（VV）系統。根據組件類型，該生態系統由插管、控制器、熱交換器、氧合器和泵浦組成，每種組件都面臨獨特的技術挑戰和售後市場考慮。根據患者類型，成人、嬰幼兒和兒童患者的臨床需求各不相同，需要採用尺寸適當的插管技術、流量曲線和監測功能。

本文檔概述了全球主要醫療保健區域的部署模式、監管影響和供應選擇，重點介紹了區域策略差異和合作機會。

區域趨勢正在影響美洲、歐洲、中東和非洲以及亞太地區的臨床應用、監管路徑和供應鏈選擇，為相關人員創造了獨特的策略環境。在美洲，成熟的三級醫療機構和綜合醫療保健系統正在擴展體外循環項目，強調方案標準化、集中培訓和機構間恢復服務。報銷框架和區域卓越中心支持強化高級護理能力，同時促進就公平的地域准入和小規模市場的能力建設展開討論。

整合系統供應商和組件專家如何在臨床性能、售後服務和數位化支援方面展開競爭，以確保長期夥伴關係？

成熟系統供應商與專業元件供應商之間的競爭，體現在臨床效能、卓越服務、可靠的耗材供應和數位化連接等方面的整合。成熟系統供應商專注於提供整合平台，以最大限度地縮短安裝時間、降低併發症風險，並透過全面的服務合約實現可預測的生命週期成本。同時，專業組件公司則專注於插管設計、氧合裝置效率和泵浦機制方面的創新，提供性能優勢，從而實現授權許可並整合到更廣泛的系統中。

為製造商和供應商提供實用策略指南，以增強體外循環系統的設計模組化、臨床培訓、供應彈性和數位服務。

產業領導企業應採取協作策略，將產品設計、臨床協作和供應鏈韌性結合，以充分發揮體外循環療法成熟的優勢。優先考慮模組化架構，以便快速更換組件並進行升級，而無需更換整個系統，從而降低整體擁有成本並提高採購柔軟性。投資臨床教育計畫和模擬中心，以縮短新團隊的學習曲線，並規範操作流程，以減少治療結果的差異。

採用透明、多方面的研究途徑，結合與臨床醫師的訪談、與供應商的對話、監管審查和技術評估，檢驗可操作的見解。

本研究將與臨床和供應鏈相關人員的直接溝通與對監管和技術文獻的系統性回顧相結合，以確保基於證據的觀點。主要資訊來源包括對重症監護醫師、心胸外科醫生、體外循環技師、採購經理和高級設備工程師的訪談，以了解臨床實踐的差異、對設備性能的預期以及採購限制。與供應商的討論重點在於生產在地化、組件籌資策略和售後服務模式。二級資訊來源包括同行評審的臨床研究、醫療設備附加檔和監管申報文件、技術白皮書以及公開的醫院採購指南，以對臨床結果和醫療設備的功能進行多方面的檢驗。

從系統層面規劃、臨床醫生培訓和供應彈性等方面對體外療法進行綜合分析，以維持臨床療效。

體外膜氧合（ECMO）已達到策略轉捩點，技術成熟與臨床整合使其成為現代重症監護體系中不可或缺的實用組成部分。醫療設備安全性的提升，以及區域專家網路和數位化監測等營運創新，正在拓展臨床應用前景，同時也凸顯了供應鏈韌性和針對性培訓的重要性。積極主動地提升採購柔軟性、建立服務和培訓夥伴關係以及實現本地化組件在地採購的相關人員，將更有能力在各種醫療環境中將臨床潛力轉化為可靠且可重複的治療效果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：體外膜氧合（ECMO）設備市場：依設備類型分類

  • 靜脈 - 動脈
  • 靜脈 - 靜脈

第9章：體外膜氧合裝置市場：依組件類型分類

  • 套管
  • 控制器
  • 熱交換器
  • 氧合器
  • 泵浦

第10章：依病患類型分類的體外膜氧合（ECMO）設備市場

  • 成人
  • 嬰兒
  • 兒童

第11章：體外膜氧合裝置市場：依應用領域分類

  • 心臟支持
    • 心源性休克
    • 開胸手術後
  • 體外心肺復甦術（CPR）
  • 呼吸輔助

第12章：體外膜氧合設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第13章：體外膜氧合（ECMO）設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：體外膜氧合（ECMO）設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：體外膜氧合（ECMO）設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國體外膜氧合系統市場

第17章：中國體外膜氧合（ECMO）設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Abiomed, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Braile Biomedica
  • CytoSorbents Corporation
  • Eurosets Srl
  • Fresenius Medical Care
  • Getinge AB
  • Hemovent NV
  • Inspira Technologies OXY BHN Ltd.
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • OriGen Biomedical, Inc.
  • Senko Medical Instrument Mfg. Co., Ltd.
  • Spectrum Medical（UK）Limited
  • Spectrum Medical Ltd.
  • Terumo Corporation
Product Code: MRR-03607F65CC95

The Extracorporeal Membrane Oxygenation Machine Market was valued at USD 579.25 million in 2025 and is projected to grow to USD 610.75 million in 2026, with a CAGR of 5.45%, reaching USD 840.14 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 579.25 million
Estimated Year [2026] USD 610.75 million
Forecast Year [2032] USD 840.14 million
CAGR (%) 5.45%

An authoritative orientation to extracorporeal membrane oxygenation as an established advanced support modality reshaping critical care pathways and procurement priorities

Extracorporeal membrane oxygenation has transitioned from a niche salvage therapy to an integral option within advanced critical care pathways, driven by incremental clinical acceptance and steady improvements in device engineering. Clinicians now view extracorporeal support as a bridge therapy that can stabilize patients through acute respiratory or cardiac crises while definitive therapies or organ recovery are pursued. Consequently, health systems and clinical teams are adapting protocols, assembling multidisciplinary ECMO teams, and investing in training and simulation to ensure safe deployment and weaning.

Technology innovators have reduced device complexity and improved circuit biocompatibility, which has increased the feasibility of deployment outside of traditional intensive care units. At the same time, regulatory scrutiny and reimbursement dynamics create both constraints and opportunities for wider adoption. As a result, stakeholders across procurement, clinical leadership, and device manufacturing are recalibrating priorities to balance clinical efficacy, operational readiness, and procurement flexibility. This introduction frames ECMO as a rapidly maturing clinical option with significant implications for care pathways, supplier relationships, and hospital resource planning.

How technological innovation combined with operational redesign and regionalized care networks is transforming extracorporeal therapy delivery and supplier relationships

The landscape for extracorporeal membrane oxygenation is being reshaped by several converging shifts that extend beyond device upgrades to influence clinical workflows, supply chains, and service models. Advances in pump technology, oxygenator efficiency, and surface coatings have reduced hemolysis and thrombotic complications, enabling longer and safer runs. Concurrently, the rise of dual-lumen cannulation strategies and percutaneous approaches has shortened deployment times and increased the portability of support, allowing for more rapid initiation in emergency and retrieval settings.

Operationally, hospitals are embedding ECMO into cardiothoracic and pulmonary care pathways, increasing routine training and simulation to ensure readiness for extracorporeal cardiopulmonary resuscitation scenarios. Telemedicine and remote monitoring tools are extending specialist oversight to smaller centers, enabling regionalized support networks and more efficient utilization of centralized expertise. On the commercial side, manufacturers are integrating digital diagnostics, plug-and-play disposables, and service contracts that emphasize uptime and lifecycle management. Taken together, these transformative forces are pushing ECMO toward greater clinical accessibility, lower procedural risk, and tighter alignment between device performance and operational workflows.

Supply chain resilience and procurement agility arising from tariff shifts in 2025 that forced reevaluation of sourcing strategies and component localization for extracorporeal systems

United States tariff changes in 2025 have introduced new dynamics for device sourcing, component procurement, and supply-chain resilience for extracorporeal membrane oxygenation systems. Import duties on select medical components and subassemblies have elevated the importance of procurement strategy, prompting device manufacturers and hospitals to reevaluate supplier footprints, component localization, and inventory policies. In response, some manufacturers accelerated qualification of alternative suppliers and secured diversified logistics channels to mitigate exposure to single-country sourcing.

These tariff-induced cost pressures encouraged a parallel emphasis on design for supply chain resilience, including modular system architectures that allow substitution of locally available components without altering clinical performance. Health systems assessed total landed cost across capital acquisition, consumables, and service contracts and increasingly considered multi-year agreements to stabilize pricing and availability. Furthermore, the tariffs stimulated dialogue between manufacturers and regulatory bodies to expedite domestic production approvals where feasible, and they reinforced the case for strategic stockpiles of critical disposables in regional centers of excellence. Ultimately, the 2025 tariff environment emphasized the need for agility in procurement and close collaboration across the clinical, regulatory, and supply-chain functions.

Segmentation-driven insights revealing how device type, component specialization, patient cohorts, clinical applications, and end-user settings shape strategic priorities

Segmentation analysis reveals differentiated dynamics across device types, components, patient cohorts, clinical applications, and end-user settings that collectively inform product strategy and go-to-market approaches. Based on device type, the field delineates between Veno Arterial systems optimized for cardiac support and Veno Venous systems tailored to respiratory support and extracorporeal oxygenation. Based on component type, the ecosystem comprises cannula, controllers, heat exchangers, oxygenators, and pumps, each carrying distinct engineering challenges and aftermarket considerations. Based on patient type, clinical requirements diverge among adults, infants, and pediatric patients, necessitating size-specific cannulation techniques, flow profiles, and monitoring capabilities.

Based on application, clinical deployment spans cardiac support, extracorporeal cardiopulmonary resuscitation, and respiratory support, with cardiac support further subdividing into cardiogenic shock and post cardiotomy interventions that demand rapid initiation and hemodynamic precision. Based on end user, adoption patterns vary across ambulatory surgical centers, hospitals, and specialty clinics, with hospitals remaining the primary locus for high-acuity cases while specialty clinics and select ambulatory settings expand capabilities for pre- and post-procedural care. Understanding these segmentation axes clarifies product development priorities, clinical training needs, and differentiated service models that manufacturers and providers must tailor to optimize both clinical outcomes and operational efficiency.

Regional strategic contrasts and collaborative opportunities that explain adoption patterns, regulatory influences, and supply choices across major global healthcare regions

Regional dynamics shape clinical adoption, regulatory pathways, and supply-chain choices across the Americas, Europe, Middle East & Africa, and Asia-Pacific, creating distinct strategic landscapes for stakeholders. In the Americas, established tertiary centers and integrated health systems have expanded extracorporeal programs, emphasizing protocol standardization, centralized training, and cross-institutional retrieval services. Reimbursement frameworks and regional centers of excellence have supported concentrated high-acuity capability while driving discussions about equitable geographic access and capacity building in smaller markets.

In Europe, Middle East & Africa, regulatory harmonization efforts and national procurement practices influence adoption cadence, with leading academic hospitals driving clinical guidelines and smaller health systems exploring partnerships or regional hubs. Training programs and mobile retrieval teams are important enablers in geographically dispersed regions. In the Asia-Pacific, rapid hospital expansion, growing critical care capacity, and targeted investments in advanced therapies have accelerated interest in extracorporeal systems, though variability in regulatory timelines and local manufacturing capabilities affects how global suppliers structure commercial entry and aftermarket support. Across all regions, cross-border collaboration on clinical registries and outcome benchmarks is increasingly shaping best practices and supplier selection criteria.

How integrated system providers and component specialists are competing on clinical performance, aftermarket service, and digital-enabled support to win long-term partnerships

Competitive dynamics among established manufacturers and specialized component suppliers are defined by a race to combine clinical performance with service excellence, consumable availability, and digital connectivity. Established system providers focus on delivering integrated platforms that minimize setup time, reduce complication risk, and offer predictable lifecycle costs through bundled service agreements. Component specialists concentrate on innovations in cannula design, oxygenator efficiency, and pump mechanics to offer performance advantages that can be licensed or incorporated into broader systems.

Across the value chain, aftermarket service and training have become differentiators, with suppliers offering simulation-based programs, remote diagnostics, and rapid-response field service to maintain clinical readiness. Partnerships between device makers and hospital networks are increasingly common, facilitating co-development of protocols, registry participation, and joint training curricula. Regulatory approvals and post-market surveillance activities favor manufacturers that maintain transparent quality systems and demonstrate sustained clinical outcomes. As capital cycles tighten, procurement teams weigh not only device performance but also supplier stability, spare-parts logistics, and the ability to support regional training and clinical governance.

Actionable strategic playbook for manufacturers and providers to strengthen design modularity, clinical training, supply resilience, and digital services for extracorporeal systems

Industry leaders should adopt a coordinated strategy that aligns product design, clinical engagement, and supply-chain resilience to capitalize on the maturation of extracorporeal therapies. Prioritize modular architectures that enable rapid substitution of components and facilitate upgrades without requiring full system replacement, thereby lowering total cost of ownership and improving procurement flexibility. Invest in clinical education programs and simulation centers to shorten the learning curve for new teams and to standardize protocols that reduce variability in outcomes.

Strengthen supplier diversification and nearshoring where feasible to mitigate tariff and logistics risk while negotiating multi-year consumable agreements to improve predictability for health systems. Expand digital capabilities to provide remote monitoring, predictive maintenance, and analytics that materially reduce downtime and support outcome benchmarking. Finally, cultivate transparent partnerships with leading clinical centers to generate real-world evidence and inform guideline development, which in turn will support broader adoption and reimbursement negotiations. These actions, carried out in parallel, will position companies and providers to deliver reliable extracorporeal care at scale while containing risk and demonstrating sustained clinical value.

A transparent, multi-source research approach combining clinician interviews, supplier engagement, regulatory review, and technical assessments to validate practical insights

This research integrates primary engagement with clinical and supply-chain stakeholders and a structured review of regulatory and technical literature to ensure an evidence-based perspective. Primary inputs included interviews with intensivists, cardiothoracic surgeons, perfusionists, procurement leaders, and senior device engineers to capture clinical practice variability, device performance expectations, and procurement constraints. Supplier discussions focused on manufacturing localization, component sourcing strategies, and aftermarket service models. Secondary sources encompassed peer-reviewed clinical studies, device labeling and regulatory filings, technical whitepapers, and publicly available hospital procurement guidelines to triangulate clinical outcomes and device feature sets.

Analytical techniques combined thematic synthesis of qualitative interviews with supply-chain mapping and technology readiness assessments to identify risk nodes and adoption enablers. Limitations include variability in institutional practice patterns and evolving regulatory decisions that can alter adoption timelines. Where possible, findings were validated across multiple stakeholder types to reduce single-source bias. The methodology emphasizes transparency and traceability so that decision-makers can align the research insights with their internal data and operational realities.

Integrated outlook on extracorporeal therapies emphasizing systems-level planning, clinician training, and supply resilience to sustain clinical impact

Extracorporeal membrane oxygenation has reached a strategic inflection point where technological maturity and clinical integration are converging to make it a practical element of modern critical care portfolios. Advances in device safety, coupled with operational innovations such as regionalized specialist networks and digital monitoring, have expanded clinical opportunities while exposing the importance of supply-chain resilience and targeted training. Stakeholders who proactively address procurement flexibility, service and training partnerships, and component localization will be best positioned to translate clinical possibility into reliable, repeatable outcomes across care settings.

Looking ahead, the most successful organizations will be those that treat extracorporeal therapy as a systems challenge rather than a single-device purchase, coupling product innovation with robust clinician education, lifecycle service offerings, and adaptive supply strategies. This integrated approach will be essential to sustain high-quality patient outcomes while managing capital and operational demands in an environment of evolving regulation and global trade dynamics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal Membrane Oxygenation Machine Market, by Device Type

  • 8.1. Veno Arterial
  • 8.2. Veno Venous

9. Extracorporeal Membrane Oxygenation Machine Market, by Component Type

  • 9.1. Cannula
  • 9.2. Controllers
  • 9.3. Heat Exchangers
  • 9.4. Oxygenators
  • 9.5. Pumps

10. Extracorporeal Membrane Oxygenation Machine Market, by Patient Type

  • 10.1. Adults
  • 10.2. Infants
  • 10.3. Pediatric

11. Extracorporeal Membrane Oxygenation Machine Market, by Application

  • 11.1. Cardiac Support
    • 11.1.1. Cardiogenic Shock
    • 11.1.2. Post Cardiotomy
  • 11.2. Extracorporeal Cardiopulmonary Resuscitation
  • 11.3. Respiratory Support

12. Extracorporeal Membrane Oxygenation Machine Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Extracorporeal Membrane Oxygenation Machine Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal Membrane Oxygenation Machine Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal Membrane Oxygenation Machine Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Extracorporeal Membrane Oxygenation Machine Market

17. China Extracorporeal Membrane Oxygenation Machine Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Abiomed, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Baxter International Inc.
  • 18.9. Braile Biomedica
  • 18.10. CytoSorbents Corporation
  • 18.11. Eurosets S.r.l.
  • 18.12. Fresenius Medical Care
  • 18.13. Getinge AB
  • 18.14. Hemovent N.V.
  • 18.15. Inspira Technologies OXY B.H.N. Ltd.
  • 18.16. LivaNova PLC
  • 18.17. Medtronic plc
  • 18.18. MicroPort Scientific Corporation
  • 18.19. Nipro Corporation
  • 18.20. OriGen Biomedical, Inc.
  • 18.21. Senko Medical Instrument Mfg. Co., Ltd.
  • 18.22. Spectrum Medical (UK) Limited
  • 18.23. Spectrum Medical Ltd.
  • 18.24. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 133. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. G7 EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. G7 EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. G7 EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 154. G7 EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. NATO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. NATO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. NATO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 161. NATO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)